Bemethyl

N/A

Report date: 2022/03/31 17:22:58

Base Information

Drug NameBemethyl
Drug Alias NameNP-135
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein synthesis stimulants
TargetsNot applicable
Therapy Area/IndicationsRenal Insufficiency, ChronicMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlgernon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlgernon Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A